2025-02-01 2026-01-31 false Capium Accounts Production 1.1 11796584 2025-02-01 2026-01-31 11796584 bus:AbridgedAccounts 2025-02-01 2026-01-31 11796584 bus:FRS102 2025-02-01 2026-01-31 11796584 bus:AuditExemptWithAccountantsReport 2025-02-01 2026-01-31 11796584 bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 11796584 bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 11796584 2025-02-01 2026-01-31 11796584 2026-01-31 11796584 bus:RegisteredOffice 2025-02-01 2026-01-31 11796584 core:WithinOneYear 2026-01-31 11796584 core:AfterOneYear 2026-01-31 11796584 1 2025-02-01 2026-01-31 11796584 bus:Director1 2025-02-01 2026-01-31 11796584 bus:Director1 2026-01-31 11796584 bus:Director1 2024-02-01 2025-01-31 11796584 2024-02-01 11796584 bus:LeadAgentIfApplicable 2025-02-01 2026-01-31 11796584 2024-02-01 2025-01-31 11796584 2025-01-31 11796584 core:WithinOneYear 2025-01-31 11796584 core:AfterOneYear 2025-01-31 11796584 bus:EntityAccountantsOrAuditors 2024-02-01 2025-01-31 11796584 bus:OrdinaryShareClass1 2025-02-01 2026-01-31 11796584 bus:OrdinaryShareClass1 2026-01-31 11796584 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 11796584 bus:OrdinaryShareClass1 2025-01-31 11796584 core:FurnitureFittings 2025-02-01 2026-01-31 11796584 core:FurnitureFittings 2026-01-31 11796584 core:FurnitureFittings 2025-01-31 11796584 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-01-31 11796584 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 11796584 core:CostValuation core:Non-currentFinancialInstruments 2026-01-31 11796584 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 11796584 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-01-31 11796584 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 11796584 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-01-31 11796584 core:Non-currentFinancialInstruments 2026-01-31 11796584 core:Non-currentFinancialInstruments 2025-01-31 11796584 core:ShareCapital 2026-01-31 11796584 core:ShareCapital 2025-01-31 11796584 core:RetainedEarningsAccumulatedLosses 2026-01-31 11796584 core:RetainedEarningsAccumulatedLosses 2025-01-31 11796584 dpl:Item1 2025-02-01 11796584 dpl:Item1 2026-01-31 11796584 dpl:Item1 2024-02-01 11796584 dpl:Item1 2025-01-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 11796584
England and Wales
R & B HEALTHCARE LIMITED
Abridged Accounts
Period of accounts Start date: 01 February 2025 End date: 31 January 2026

R & B Healthcare Limited Contents Page For the year ended 31 January 2026
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

R & B Healthcare Limited Accountants' Report For the year ended 31 January 2026
Report to the directors on the preparation of the unaudited statutory accounts of R & B Healthcare Limited for the year ended 31 January 2026. In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of R & B Healthcare Limited for the year ended 31 January 2026 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com/. This report is made solely to the Board of Directors of R & B Healthcare Limited, as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of R & B Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of R & B Healthcare Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than R & B Healthcare Limited and its Board of Directors as a body for our work or for this report. It is your duty to ensure that R & B Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of R & B Healthcare Limited. You consider that R & B Healthcare Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the accounts of R & B Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts 31 January 2026. .................................................... Secure Accounts Limited. Suite 2A, 6 Floor Cobalt Square, 83-85 Hagley Road Birmingham B16 8QG 27 February 2026 1

R & B Healthcare Limited Statement of Financial Position As at 31 January 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 7,411 |  | 3,376
|  | 7,411 |  | 3,376
Current assets |  |  |
Debtors |  | 0 |  | 2,470
Cash at bank and in hand |  | 51,714 |  | 75,263
|  | 51,714 |  | 77,733
Creditors: amount falling due within one year |  | (7,238) |  | (53,788)
Net current assets |  | 44,476 |  | 23,945
Total assets less current liabilities |  | 51,887 |  | 27,321
Net assets |  | 51,887 |  | 27,321
Capital and reserves |  |  |
Called up share capital | 4 | 100 |  | 100
Profit and loss account |  | 51,787 |  | 27,221
Shareholders' funds |  | 51,887 |  | 27,321
For the year ended 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 27 February 2026 and were signed by:
------------------------------- Bhagyalaxmi Acharya Director
2

R & B Healthcare Limited Notes to the Abridged Financial Statements For the year ended 31 January 2026
General Information R & B Healthcare Limited is a private company, limited by shares, registered in England and Wales, registration number 11796584, registration address 4 Bronze Road, Cawston, Rugby, CV22 7XN. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Fixtures and Fittings | 25 Reducing Balance
2. | Average number of employees Average number of employees during the year was 1 (2025 : 1).
3. | Tangible fixed assets
Cost or valuation | Fixtures and Fittings |  | Total
| £ |  | £
At 01 February 2025 | 4,501 |  | 4,501
Additions | 6,505 |  | 6,505
Disposals | - |  | -
At 31 January 2026 | 11,006 |  | 11,006
Depreciation
At 01 February 2025 | 1,125 |  | 1,125
Charge for year | 2,470 |  | 2,470
On disposals | - |  | -
At 31 January 2026 | 3,595 |  | 3,595
Net book values
Closing balance as at 31 January 2026 | 7,411 |  | 7,411
Opening balance as at 01 February 2025 | 3,376 |  | 3,376
4. | Share Capital
Allotted, called up and fully paid | 2026 £ |  | 2025 £
--- | --- | --- | ---
100 Class A shares of £1.00 each | 100 |  | 100
| 100 |  | 100
3